John L Gordon

Title: John L Gordon: Innovator in Pharmaceutical Compositions

Introduction

John L Gordon is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating inflammation. His work has implications for various medical conditions, showcasing the importance of research and development in healthcare.

Latest Patents

John L Gordon holds a patent for pharmaceutical liposome compositions that contain an anti-inflammatory steroid derivative, specifically cortisol 21-hexadecanoate. This invention focuses on a method of treating inflammation at a site involving an enclosed cavity, such as in cases of rheumatic disease. The method involves injecting the pharmaceutical liposome composition into the affected cavity. Additionally, he has specified new steroid derivatives, including fluocinolone acetamide 21-hexadecanoate, which further enhance the therapeutic potential of his compositions.

Career Highlights

Throughout his career, John L Gordon has worked with prominent organizations, including Imperial Chemical Industries Limited and the National Research Development Corporation. His experience in these companies has allowed him to refine his expertise in pharmaceutical research and development, contributing to his innovative work in the field.

Collaborations

John has collaborated with notable individuals in his field, including John T Dingle and Geraint Jones. These collaborations have likely enriched his research and led to advancements in pharmaceutical compositions.

Conclusion

John L Gordon's contributions to pharmaceutical innovations demonstrate the critical role of inventors in advancing medical treatments. His patented work on liposome compositions highlights the potential for new therapies in managing inflammation.